A CLINICAL CASE OF NON-SMALL CELL THERAPY LUNG CANCER WITH PD-L1 EXPRESSION
... Immunotherapy by choosing a personalized treatment based on efficacy, favorable toxicity profile and tolerability consistent with the results of randomized clinical trials (KEYNOTE) is a promising new approach to the treatment of metastatic non-small cell lung cancer. Currently, in the treatment of non-small cell lung cancer, the range of immunotherapeutic drugs has significantly expanded, the use of which makes it possible to achieve tumor control while maintaining the quality of life of patients and ...
Изменен: 28.04.2024Путь: Главная / Home / Publications
Результаты поиска 1 1 из 1
Начало | Пред. | 1 | След. | Конец
Сортировать по релевантности | Отсортировано по дате